Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities
- PMID: 33933818
- PMCID: PMC8050399
- DOI: 10.1016/j.jneuroim.2021.577578
Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities
Abstract
The emergence of the novel coronavirus (SARS-CoV-2) and the worldwide spread of the coronavirus disease (COVID-19) have led to social regulations that caused substantial changes in manners of daily life. The subsequent loneliness and concerns of the pandemic during social distancing, quarantine, and lockdown are psychosocial stressors that negatively affect the immune system. These effects occur through mechanisms controlled by the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenocortical (HPA) axis that alter immune regulation, namely the conserved transcriptional response to adversity (CTRA), which promotes inflammation and diminishes antiviral responses, leading to inadequate protection against viral disease. Unhealthy eating habits, physical inactivity, sleep disturbances, and mental health consequences of COVID-19 add on to the pathological effects of loneliness, making immunity against this ferocious virus an even tougher fight. Therefore, social isolation, with its unintended consequences, has inherently paradoxical effects on immunity in relation to viral disease. Though this paradox can present a challenge, its acknowledgment can serve as an opportunity to address the associated issues and find ways to mitigate the adverse effects. In this review, we aim to explore, in detail, the pathological effects of the new social norms on immunity and present suggested methods to improve our physical, psychological, and healthcare abilities to fight viral infection in the context of the COVID-19 pandemic.
Keywords: COVID-19; CTRA; Hypothalamic-pituitary-adrenocortical axis; IMMERS; Immune booster; Immune regulation; Immunoemotional regulatory system; Loneliness; Pandemic; Quarantine; Stress.
Copyright © 2021 Elsevier B.V. All rights reserved.
References
-
- Acquah C., et al. Aptamers: an emerging class of bioaffinity ligands in bioactive peptide applications. Crit. Rev. Food Sci. Nutr. 2020;60(7):1195–1206. - PubMed
-
- Ahanchian H., et al. Death due to COVID-19 in an infant with combined immunodeficiencies. Endocr. Metab. Immune Disord. Drug Targets. 2020 doi: 10.2174/1871530320666201021142313. https://www.eurekaselect.com/187080/article ahead of print. - DOI - PubMed
-
- Aksungar F.B., Topkaya A.E., Akyildiz M. Interleukin-6, C-reactive protein and biochemical parameters during prolonged intermittent fasting. Ann. Nutr. Metab. 2007;51(1):88–95. - PubMed
-
- Aldrin Joshua A., Devi R. Gayatri, Jayaraj G. Knowledge and awareness on natural dietary immunoboosters to combat covid 19-a survey. Int. J. Res. Pharm. Sci. 2020;11(Special Issue 1):609–617.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
